Related Experiment Video
Updated: Dec 6, 2025

Isolation of Tonsillar Mononuclear Cells to Study Ex Vivo Innate Immune Responses in a Human Mucosal Lymphoid Tissue
Published on: June 14, 2020
What chances do children have against COVID-19? Is the answer hidden within the thymus?
Hatice Güneş1, Serpil Dinçer1, Can Acıpayam2
1Department of Pediatrics, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey.
Insights
Children’s thymus activity and T lymphocyte function appear to protect them from severe COVID-19. Maintaining thymus health may offer a novel therapeutic strategy against the virus.
Area of Science:
- Immunology
- Virology
- Pediatrics
Background:
- The SARS-CoV-2 pandemic poses a significant threat to global health.
- Children are less frequently affected by SARS-CoV-2, often exhibiting milder disease compared to adults.
- The thymus plays a crucial role in adaptive immunity, particularly through T lymphocyte development and function.
Purpose of the Study:
- To investigate the role of thymus activity and T lymphocyte function in pediatric protection against SARS-CoV-2.
- To explore potential therapeutic strategies targeting the thymus for COVID-19 treatment.
Main Methods:
- This study is based on existing knowledge of viral pathogenesis, innate and adaptive immunity, and thymus function.
- It reviews the known impact of SARS-CoV-2 on children and the immunological characteristics of pediatric populations.
- The pathogenesis of viral infections and the role of regulatory T cells (T-regs) were considered.
Main Results:
- Children's thymus is highly active, supporting robust T lymphocyte function, crucial for immune response regulation.
- Age-related decline in thymus function correlates with impaired immune control and increased inflammation, as seen in COVID-19's 'inflammatory storm'.
- The thymus's capacity to replace virus-induced apoptotic T cells is a key factor in pediatric SARS-CoV-2 pathogenesis.
Conclusions:
- Thymus activity and T lymphocyte function in children are speculated to provide protection against SARS-CoV-2.
- Interventions aimed at stimulating or preventing inhibition of the thymus could be potential therapeutic components for COVID-19.
- Further research is warranted to validate these findings and explore thymus-centric therapeutic approaches.
Abstract:
A new type of coronavirus named as SARS-CoV-2 pandemic has begun to threaten human health. As with other types of coronaviruses, SARS-CoV-2 affects children less frequently, and it has been observed that the disease is mild. In the pathogenesis of a standard viral infection, the pathogen's contact with the mucosa is initially followed by an innate immunity response. T cells are the primary decisive element in adaptive immunity capability. For this reason, the adaptive immune response mediated by the thymus is a process that regulates the immune response responsible for preventing invasive damage from a virus. Regulatory T cells (T-reg) are active during the early periods of life and have precise roles in immunomodulation. The thymus is highly active in the intrauterine and neonatal period; it begins to shrink after birth and continues its activity until adolescence. The loss of T-reg function by age results in difficulty with the control of the immune response, increased inflammation as shown in coronavirus disease (COVID-19) as an inflammatory storm. Also, the thymus is typically able to replace the T cells destroyed by apoptosis caused by the virus. Thymus and T cells are the key factors of pathogenesis of SARS-CoV-2 in children.Conclusion: We speculated that thymus activity and T lymphocyte function in children protect them against the virus effects. Stimulating and preventing the inhibition of the thymus can be possible treatment components against COVID-19. What is Known: • The SARS-CoV-2 infection does not often progress with an invasive clinic in children. • Thymus activity and T lymphocyte functions are highly active in children. What is New: • Effective thymus activity and T lymphocyte function in children protect them against the invasive SARS-CoV-2 infection. • Stimulating and preventing the inhibition of the thymus can be possible treatment components against COVID-19.
Related Concept Videos
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

